Samantha E. Cleek

FDA investigator

Appears on 4 documents from 2024 to 2025, mostly at sites in Georgia. Most often cites testing and release for distribution (21 CFR 211.165(b)).

4
Documents on file
7.3
Observations per 483
2024
First seen
2025
Most recent

What they cite most

From 29 observations

Activity by year

2024: 2, 2025: 2

Where

Georgia 2 · Singapore 1 · Texas 1

Is Samantha E. Cleek coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Winder Laboratories, LLCAug 5, 2025 · Winder, Georgia
483 Osmotica Pharmaceutical US LLCMay 2, 2025 · Marietta, Georgia
483 Haw Par Healthcare Ltd.Sep 27, 2024 · Singapore, Singapore
483 Analytical Food Laboratories IncMay 17, 2024 · Grand Prairie, Texas

About this profile

What does Samantha E. Cleek inspect?

Samantha E. Cleek appears on 4 documents on file covering 4 sites, mostly in Georgia.

What do they cite most often?

21 CFR 211.165(b) (testing and release for distribution), followed by 21 CFR 211.100(a) and 21 CFR 211.142.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Samantha E. Cleek is dated Aug 5, 2025.